Shruti Bhat PhD, MBA, Operations Excellence Expert
  • Home
  • About Shruti
  • Books
  • Insights
  • Operational Excellence
  • Research
    • Innovation Management
    • Leading Research and Development
    • Developer's Diary
  • Case Studies
  • Tools
    • Whitepapers
    • Articles >
      • Business Transformation
      • Process Improvement
      • Business Continuity
      • Change Management
      • Digital Transformation
      • Quality Improvement
    • Checklists and Templates
    • Free eBook
    • Videos
  • Blog
  • Engage Shruti
    • Consulting >
      • Operational Excellence Consulting
      • Business Transformation Consulting
      • Innovation Management Consulting
    • Workshops
  • Contact

Vaginal and Uterine Controlled Release Drug Delivery Systems

5/16/2009

0 Comments

 
Sustained and controlled-release devices for drug delivery in the vaginal and uterine areas are most often for the delivery of contraceptive steroid hormones.  The advantages in administration by this route--prolonged release, minimal systemic side effects, and an increase in bioavailability-- allow for less total drug than with an oral dose.  First-pass metabolism that inactivates many steroids hormones can be avoided.

One such application is the medicated vaginal ring.  Therapeutic levels of medroxy progesterone have been achieved at a total dose that was one-sixth the required oral dose and ring expulsion, to name a few.  Microcapsules have also recently been useful for vaginal and cervical delivery.  Local progesterone release from this dosage form can alter cervical mucus to interfere with sperm migration.  

Other steroids have also attained sustained delivery by an intracervical system.  The sustained release of progesterone from various polymers given vaginally have also been found useful in cervical opening and induction of labor.
 

A more common contraceptive device is the intrauterine device (IUD).  The first intrauterine devices used were of the unmedicated type.  These have received increased attention since the use of polythylene plastics and silicone rubbers.  These materials had the ability to resume their shape following distortion.  Because they are unmedicated, these IUDs cannot be classified as sustained release products.  

​It is believed their mechanism of action is due to local endometrial responses, both cellular and cytosecretory.  Initial investigations of these devices led to the conclusions that the larger the device, the more effective it was in preventing pregnancy.  Large devices, however, increased the possibility of uterine cramps, bleeding, and expulsion of the device.
 

Efforts to improve IUD’s have led to the use of medicated devices.  Two types of agents are generally used, contraceptive metals and steroid hormones.  The metal device is exemplified by the CU-7, a polypropylene plastic device in the shape of number 7.  Copper is released by a combination of ionization and chelation from a copper wire wrapped around the vertical limb.  This system is effective for up to 40 months.  

The hormone-releasing devices have a closer resemblance to standard methods of sustained release because they involve the release of a steroid compound by diffusion.  

In the coming blog posts, we shall discuss on controlled release injections, implant delivery systems, quality control of CRDDS, Regulatory considerations and Novel CRDDS ...
Follow Shruti on Twitter, Facebook, YouTube, LinkedIn
0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    Shruti Bhat, global leader in business turnaround, operational excellence and continuous improvement
    To contact Dr. Shruti Bhat text or WhatsApp at 1.403.969.6219

    New Book Released!

    Revolutionizing Industries with Lean Six Sigma

    Shruti's YouTube Channel ...

    Picture

    Blog Categories

    All
    3D Printing
    Agile
    Artificial Intelligence
    Automation
    Biotechnology
    Books
    Business Continuity
    Business Turnaround
    Case Studies
    Change Management
    Checklists
    Chemical Industry
    Continuous Improvement
    Design Thinking
    Digitalization
    Drug Delivery
    External News Links
    Hall Of Fame
    Healthcare
    Hoshin Kanri
    HR Development
    Innovation
    Insights
    ISO
    Just In Time
    Kaizen
    Leadership
    LEAN
    Lean Six Sigma
    Life Sciences
    Machine Learning
    Manufacturing
    Medical Devices
    Mistake Proofing
    Motivational Cards
    MSMEs
    Nanotechnology
    Operational Excellence
    Packaging
    Patents
    Personal Products
    Process Improvement
    Product Development
    Productivity Increase
    QbD
    Quality Management
    R&D Leadership
    Robotics
    Service Industry
    Six Sigma
    Strategy
    Supply Chain Logistics
    Telecom Industry
    Templates
    TQM
    Videos
    Voice Of Customer
    Whitepaper
    Workshops

    Shruti's books...

    Picture
    top ten strategic decision-making tools for operational excellence
    shruti bhat, business process management, continuous improvement
    kaizen for pharmaceutcials, medical devices and biotech industry book by Dr Shruti Bhat
    Book on Continuous improvement tools by Dr Shruti Bhat
    kaizen for leaders, continuous process improvement tool to increase profit and organizational excellence by shruti bhat
    kaizen, shruti bhat, continuous improvement, quality, operations management
    how to lead a successful business transformation
    leading organizations through crisis
    emotional intelligence
    how to overcome challenges of creating effective teams
    modular kaizen Vs Blitz kaizen
    How to increase employee engagement as a new boss

Connect with Dr. Shruti Bhat at- ​Twitter, YouTube, LinkedIn​

© Copyright 1992- 2025 Dr. Shruti Bhat ALL RIGHTS RESERVED.
See Terms and Conditions for details on this site usage.
Subscribe to Operational Excellence Academy YouTube Channel
​Subscribe to Operational Excellence Academy YouTube Channel
SHRUTI BHAT, CONTACT
Click to connect.
Created by Macro2Micro Media